Remove 2030 Remove Disease Remove Drug Research
article thumbnail

Possible adulticidal drugs for Onchocerca volvulus

Drug Target Review

Some report that they believe that if they don’t take the medication, they may develop onchocerciasis-related severe skin diseases and may go blind (river blindness) and would prefer a treatment that does not repeat every year. Need for adulticidal drugs More than 99 percent of countries worldwide has been affected by this disease.

Drugs 105
article thumbnail

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research

Vial

In this article, we will define preclinical and clinical CROs, as well as highlight the unique needs and challenges of these organizations in their respective stages of drug research. billion by 2030 at a compound annual growth rate (CAGR) of 7.5% between 2024 and 2030. between 2024 and 2030. over this period.

article thumbnail

World Malaria Day 2021

The Pharma Data

The COVID-19 pandemic highlights the importance of robust health systems to respond to disease outbreaks and to control other deadly diseases such as malaria. Despite the tremendous progress made in combating malaria in the past two decades, one child still dies from the disease every two minutes. The EDCTP grant of EUR 21.9